US Physical Therapy (USPH) Insider Plans Sale of 700 Shares via Schwab
Rhea-AI Filing Summary
US Physical Therapy, Inc. (USPH) filed a Form 144 proposing the sale of 700 shares of common stock through Charles Schwab & Co., Inc. The filing lists an approximate sale date of 08/25/2025 and reports an aggregate market value of $60,119. It shows total shares outstanding of 15,204,119, indicating the proposed sale represents a very small fraction of the companys outstanding stock. The shares were acquired on 01/01/2025 as employee equity compensation (1,208 shares reported acquired). The filer reports no sales in the past three months.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small insider sale notice; amount is immaterial relative to outstanding shares.
The Form 144 notifies the market of a proposed sale of 700 shares valued at $60,119 via Charles Schwab with an approximate trade date of 08/25/2025. Against 15.2 million shares outstanding, the position is negligible, suggesting limited market impact. The securities were acquired as employee equity compensation on 01/01/2025. No prior sales in the past three months are reported, which reduces concerns about accelerated insider liquidation.
TL;DR: Filing appears routine and compliant; standard attestation included.
The notice includes the required attestation that the seller is not aware of undisclosed material adverse information and references the Rule 10b5-1 plan language. Broker details and acquisition method are disclosed, and the filing indicates no recent sales to aggregate. From a compliance perspective, the form contains the standard disclosures expected for an insider sale arising from equity compensation.